 Arnon Haran
Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leukemia, Myeloid, Acute | 6 | 2026 | 682 | 0.780 |
Why?
| | Lymphoma | 1 | 2023 | 232 | 0.710 |
Why?
| | Central Nervous System Neoplasms | 1 | 2023 | 173 | 0.680 |
Why?
| | Mannans | 1 | 2021 | 5 | 0.680 |
Why?
| | Invasive Pulmonary Aspergillosis | 1 | 2021 | 7 | 0.670 |
Why?
| | Antigens, Fungal | 1 | 2021 | 28 | 0.670 |
Why?
| | False Positive Reactions | 1 | 2021 | 121 | 0.660 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 851 | 0.570 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2021 | 636 | 0.550 |
Why?
| | Gastrectomy | 3 | 2024 | 161 | 0.490 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2025 | 293 | 0.480 |
Why?
| | Antimetabolites, Antineoplastic | 2 | 2026 | 105 | 0.420 |
Why?
| | Glucagon-Like Peptide 1 | 2 | 2024 | 146 | 0.360 |
Why?
| | fms-Like Tyrosine Kinase 3 | 2 | 2025 | 49 | 0.270 |
Why?
| | Immunoglobulin Light-chain Amyloidosis | 1 | 2025 | 8 | 0.230 |
Why?
| | Sulfonamides | 3 | 2024 | 580 | 0.220 |
Why?
| | Azacitidine | 1 | 2026 | 156 | 0.220 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2025 | 675 | 0.220 |
Why?
| | Antibodies, Bispecific | 1 | 2025 | 64 | 0.220 |
Why?
| | Bariatric Surgery | 3 | 2024 | 242 | 0.210 |
Why?
| | Somatostatin | 1 | 2024 | 51 | 0.210 |
Why?
| | Weight Loss | 4 | 2024 | 836 | 0.210 |
Why?
| | Leucovorin | 1 | 2023 | 101 | 0.200 |
Why?
| | Mutation | 2 | 2025 | 4089 | 0.200 |
Why?
| | Methotrexate | 1 | 2023 | 240 | 0.180 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 4 | 2025 | 1953 | 0.180 |
Why?
| | Central Nervous System | 1 | 2023 | 281 | 0.170 |
Why?
| | Aspergillus | 1 | 2021 | 18 | 0.170 |
Why?
| | Hematologic Neoplasms | 1 | 2023 | 161 | 0.170 |
Why?
| | Nocardia Infections | 1 | 2021 | 11 | 0.170 |
Why?
| | Galactose | 1 | 2021 | 34 | 0.170 |
Why?
| | Neoplasm, Residual | 3 | 2026 | 139 | 0.160 |
Why?
| | Gastric Bypass | 1 | 2022 | 125 | 0.160 |
Why?
| | Nuclear Proteins | 1 | 2024 | 748 | 0.150 |
Why?
| | Terminal Care | 1 | 2023 | 279 | 0.150 |
Why?
| | Glucose | 2 | 2022 | 1047 | 0.150 |
Why?
| | Obesity, Morbid | 1 | 2022 | 281 | 0.140 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2024 | 1137 | 0.130 |
Why?
| | Mice, Knockout | 1 | 2024 | 3121 | 0.130 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 3 | 2024 | 279 | 0.120 |
Why?
| | Insulin Resistance | 2 | 2022 | 1241 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1985 | 0.120 |
Why?
| | Retrospective Studies | 5 | 2026 | 17066 | 0.110 |
Why?
| | Obesity | 2 | 2024 | 3077 | 0.100 |
Why?
| | Mice, Obese | 2 | 2024 | 66 | 0.100 |
Why?
| | Humans | 13 | 2026 | 144759 | 0.090 |
Why?
| | Liver | 1 | 2021 | 1887 | 0.090 |
Why?
| | Aged | 5 | 2026 | 25913 | 0.090 |
Why?
| | Prognosis | 3 | 2025 | 4282 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 2 | 2024 | 240 | 0.090 |
Why?
| | Recurrence | 2 | 2024 | 1135 | 0.080 |
Why?
| | Insulin | 1 | 2021 | 2507 | 0.080 |
Why?
| | Treatment Outcome | 4 | 2026 | 11679 | 0.080 |
Why?
| | Male | 7 | 2026 | 72315 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2875 | 0.070 |
Why?
| | Mice | 4 | 2024 | 18339 | 0.050 |
Why?
| | Disease-Free Survival | 1 | 2026 | 769 | 0.050 |
Why?
| | Remission Induction | 1 | 2024 | 307 | 0.050 |
Why?
| | Transplantation, Homologous | 1 | 2024 | 415 | 0.050 |
Why?
| | Administration, Oral | 1 | 2026 | 847 | 0.050 |
Why?
| | Aniline Compounds | 1 | 2023 | 119 | 0.050 |
Why?
| | Tertiary Care Centers | 1 | 2023 | 189 | 0.050 |
Why?
| | Salvage Therapy | 1 | 2023 | 162 | 0.050 |
Why?
| | Mice, Inbred C57BL | 2 | 2024 | 5992 | 0.040 |
Why?
| | Mice, Inbred ICR | 1 | 2021 | 113 | 0.040 |
Why?
| | Adult | 4 | 2026 | 40449 | 0.040 |
Why?
| | Animals | 4 | 2024 | 38058 | 0.040 |
Why?
| | Birth Weight | 1 | 2022 | 522 | 0.040 |
Why?
| | Young Adult | 2 | 2025 | 14105 | 0.030 |
Why?
| | Age Factors | 1 | 2024 | 3333 | 0.030 |
Why?
| | Female | 4 | 2026 | 78271 | 0.030 |
Why?
| | Palliative Care | 1 | 2023 | 1002 | 0.030 |
Why?
| | Blood Glucose | 1 | 2024 | 2327 | 0.030 |
Why?
| | Middle Aged | 2 | 2026 | 35875 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2024 | 8265 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2022 | 4557 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 3185 | 0.020 |
Why?
| | Pregnancy | 1 | 2022 | 7190 | 0.020 |
Why?
| | Adolescent | 1 | 2025 | 22428 | 0.010 |
Why?
|
|
Haran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|